Activist 13D/13G Filings - Navidea Biopharmaceuticals, Inc. (NAVB)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company‚Äôs equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2023-07-03
6:39 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.52,131,254
75.04%
21,855,950increase
(+72.19%)
View
2023-07-03
4:01 pm
Unchanged
13GNavidea Biopharmaceuticals, Inc.
NAVB
Bain Irwin Allen4,000,000
4.73%
0
(Unchanged)
View
2023-06-30
4:01 pm
Purchase
13GNavidea Biopharmaceuticals, Inc.
NAVB
Bain Irwin Allen4,000,000
4.73%
2,053,383increase
(+105.48%)
View
2023-06-16
4:20 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.30,275,304
52.85%
11,508,672increase
(+61.33%)
View
2022-10-06
2:51 pm
Purchase
13GNavidea Biopharmaceuticals, Inc.
NAVB
Bain Irwin Allen1,946,617
6.23%
1,946,617increase
(New Position)
View
2022-09-22
3:03 pm
Sale
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.18,766,632
45.7%
-533decrease
(-0.00%)
View
2022-09-14
3:25 pm
Sale
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.18,767,165
45.7%
-10,139decrease
(-0.05%)
View
2022-09-09
5:59 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.18,777,304
45.7%
8,491,133increase
(+82.55%)
View
2022-04-22
2:58 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.10,286,171
31.6%
54,957increase
(+0.54%)
View
2021-07-23
4:27 pm
Unchanged
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.10,231,214
32.8%
0
(Unchanged)
View
2021-06-15
11:46 am
Unchanged
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.10,231,214
32.8%
0
(Unchanged)
View
2021-04-05
5:00 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.10,231,214
33.3%
267,530increase
(+2.69%)
View
2021-03-11
5:07 pm
Unchanged
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.9,963,684
33.33%
0
(Unchanged)
View
2021-03-05
5:24 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.9,963,684
33.33%
1,906,383increase
(+23.66%)
View
2020-12-29
4:15 pm
Unchanged
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.8,057,301
30.2%
0
(Unchanged)
View
2020-09-02
5:18 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.8,057,301
30%
5,000increase
(+0.06%)
View
2020-02-26
4:35 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.8,052,301
33.2%
2,373,529increase
(+41.80%)
View
2019-12-12
4:32 pm
Purchase
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.5,678,772
28.2%
555,555increase
(+10.84%)
View
2019-06-24
5:15 pm
Sale
13DNavidea Biopharmaceuticals, Inc.
NAVB
Scott John K Jr.5,123,217
28.4%
-16,983,990decrease
(-76.83%)
View
2019-06-24
4:36 pm
Unchanged
13GNavidea Biopharmaceuticals, Inc.
NAVB
ARMISTICE CAPITAL LLC0
0%
0
(Unchanged)
View